1 | 3400930060797 | - | - | - | - | 1件: 36 36 |
2 | ABH001 | 1件: ABH001 ABH001 | - | - | - | 1件: 36 36 |
3 | AC-203 | - | - | - | - | 1件: 36 36 |
4 | AGLE 102 | - | - | - | - | 1件: 36 36 |
5 | ALEMTUZUMAB | 1件: Alemtuzumab Alemtuzumab | 1件: D02802
D02802
| 1件: CD52 CD52 💬 | - | 17件: 13 13, 15, 19, 20, 36, 43, 44, 46, 51, 60, 63, 65, 85, 96, 164, 283, 284 |
6 | ALLANTOIN | 1件: Allantoin Allantoin | 1件: D00121
D00121
| - | - | 1件: 36 36 |
7 | ALLANTOINA | - | - | - | - | 1件: 36 36 |
8 | Allo-APZ2-EB | - | - | - | - | 1件: 36 36 |
9 | ALLO-ASC-DFU | - | - | - | - | 1件: 36 36 |
10 | ALLOGENEIC ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS EXPANDED | - | - | - | - | 2件: 36 36, 53 |
11 | Allogeneic adipose tissue-derived MSC | - | - | - | - | 1件: 36 36 |
12 | Allogeneic mesenchymal stromal cells | 1件: Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | 1件: 36 36 |
13 | Allogeneic skin-derived ABCB5-positive mesenchymal stem cells | - | - | - | - | 1件: 36 36 |
14 | Allogenic mesenchymal stromal cells | 1件: Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | 1件: 36 36 |
15 | Alwextin cream | - | - | - | - | 1件: 36 36 |
16 | Anti-Thymocyte Globulin | - | - | - | - | 18件: 11 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 164, 283, 284, 285 |
17 | ASC | - | - | - | - | 4件: 36 36, 51, 96, 97 |
18 | AVCN583601 (3% Cannabidiol cream) | 1件: Cannabidiol Cannabidiol | 1件: D10915
D10915
| 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 36 36 |
19 | BIOOPA dressing | - | - | - | - | 1件: 36 36 |
20 | BIRCH BARK EXTRACT | 1件: Birch bark extract Birch bark extract | - | - | - | 1件: 36 36 |
21 | Blood test | - | - | - | - | 6件: 36 36, 51, 86, 113, 162, 299 |
22 | Bone marrow infusion | - | - | - | - | 1件: 36 36 |
23 | Bone marrow or umbilical cord blood (UCG) stem cell transplantation | - | - | - | - | 1件: 36 36 |
24 | Botulinic toxin | - | - | - | - | 1件: 36 36 |
25 | Broccoli | 1件: Broccoli Broccoli | - | - | - | 3件: 36 36, 97, 299 |
26 | BUSILVEX | 1件: Busulfan Busulfan | 1件: D00248
D00248
| - | - | 4件: 19 19, 36, 60, 65 |
27 | Busulfan | 1件: Busulfan Busulfan | 1件: D00248
D00248
| - | - | 13件: 19 19, 20, 28, 36, 49, 51, 60, 65, 164, 274, 284, 285, 326 |
28 | CALCIPOTRIOL | 1件: Calcipotriol Calcipotriol | 1件: D01125
D01125
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 36 36 |
29 | Cannabidiol | 1件: Cannabidiol Cannabidiol | 1件: D10915
D10915
| 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 18件: 6 6, 8, 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 |
30 | CANNABINOL | 1件: Cannabinol Cannabinol | - | - | - | 1件: 36 36 |
31 | Cannabinol (CBN) | 1件: Cannabinol Cannabinol | - | - | - | 1件: 36 36 |
32 | CBD | - | - | - | - | 12件: 2 2, 6, 8, 13, 36, 46, 140, 144, 145, 156, 158, 206 |
33 | CBN | - | - | - | - | 1件: 36 36 |
34 | CCP-020 | - | - | - | - | 1件: 36 36 |
35 | Cell transplantation | - | - | - | - | 1件: 36 36 |
36 | COL7A1-SIN retroviral vector engineered autologous tissue-engineered skin | - | - | - | - | 1件: 36 36 |
37 | Cultured allogeneic fibroblasts | - | - | - | - | 1件: 36 36 |
38 | CX501 | 1件: CX501 CX501 | - | - | - | 1件: 36 36 |
39 | Cyclophosphamide | 1件: Cyclophosphamide Cyclophosphamide | 2件: D00287
D00287
,
D07760
| - | - | 45件: 11 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 |
40 | Cyclosporine | 1件: Cyclosporine Cyclosporine | 1件: D00184
D00184
| 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 37件: 11 11, 19, 20, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 107, 162, 164, 222, 226, 228, 234, 283, 284, 285, 302 |
41 | Cyclosporine A | 1件: Cyclosporine Cyclosporine | 1件: D00184
D00184
| 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 11件: 19 19, 20, 36, 49, 50, 53, 58, 60, 107, 234, 283 |
42 | Células madre mesenquimales haploidénticas derivadas de médula ósea | - | - | - | - | 1件: 36 36 |
43 | Delta-9-tetrahydrocannabinol | 1件: Dronabinol Dronabinol | 1件: D00306
D00306
| 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 3件: 8 8, 13, 36 |
44 | DIACEREIN | 1件: Diacerein Diacerein | 1件: D07270
D07270
| - | - | 3件: 36 36, 46, 63 |
45 | Diacerein 1% Ointment | 1件: Diacerein Diacerein | 1件: D07270
D07270
| - | - | 1件: 36 36 |
46 | Diacerin cream | - | - | - | - | 1件: 36 36 |
47 | Donor mesenchymal stem cell infusions | - | - | - | - | 1件: 36 36 |
48 | Dysport | 1件: Botulinum toxin type A Botulinum toxin type A | 1件: D00783
D00783
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 2件: 13 13, 36 |
49 | Dysport® (Botulinumtoxin A (Btx A)) | 1件: Botulinum toxin type A Botulinum toxin type A | 1件: D00783
D00783
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 1件: 36 36 |
50 | EB-101 | - | - | - | - | 1件: 36 36 |
51 | Episalvan | 1件: Betulinic Acid Betulinic Acid | - | - | - | 1件: 36 36 |
52 | Episalvan gel | 1件: Betulinic Acid Betulinic Acid | - | - | - | 1件: 36 36 |
53 | Erythrocine | - | - | - | - | 1件: 36 36 |
54 | Erythrocine oral | - | - | - | - | 1件: 36 36 |
55 | Erythromycin | 1件: Erythromycin Erythromycin | 9件: D00140
D00140
,
D00851
,
D01361
,
D02009
,
D02184
,
D02523
,
D02524
,
D02525
,
D04054
| - | - | 5件: 6 6, 36, 164, 228, 291 |
56 | Erythromycine | - | - | - | - | 1件: 36 36 |
57 | Ex-vivo expanded autologous human keratinocytes suspension containing epidermal stem cells genetically modified with a gamma-retroviral (rv) vector expressing the full-length LAMB3 cDNA. | - | - | - | - | 1件: 36 36 |
58 | FCX-007 (dabocemagene autoficel | - | - | - | - | 1件: 36 36 |
59 | Fibroblasts | - | - | - | - | 1件: 36 36 |
60 | Fludarabine | 1件: Fludarabine Fludarabine | 2件: D01907
D01907
,
D07966
| 1件: RRM1 RRM1 💬 | 5件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬 | 18件: 13 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 286, 326 |
61 | Fludarabine phosphate | 2件: Fludarabine Fludarabine, Phosphate ion | 2件: D01907
D01907
,
D07966
| 1件: RRM1 RRM1 💬 | 5件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬 | 12件: 28 28, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286 |
62 | Gene-modified autologous fibroblasts | - | - | - | - | 1件: 36 36 |
63 | Genetically corrected cultured epidermal autograft (ATMP) | - | - | - | - | 1件: 36 36 |
64 | Gentamicin | 1件: Gentamicin Gentamicin | 2件: D01063
D01063
,
D08013
| - | - | 3件: 36 36, 113, 299 |
65 | Gentamicin Sulfate | 2件: Gentamicin Gentamicin, Sulfate ion | 2件: D01063
D01063
,
D08013
| - | - | 1件: 36 36 |
66 | Gentamicin sulfate 0.1% ointment | 2件: Gentamicin Gentamicin, Sulfate ion | 2件: D01063
D01063
,
D08013
| - | - | 1件: 36 36 |
67 | Gentamicin Sulfate, Injectable | 2件: Gentamicin Gentamicin, Sulfate ion | 2件: D01063
D01063
,
D08013
| - | - | 1件: 36 36 |
68 | Granulocyte Colony Stimulating Factor | 1件: Filgrastim Filgrastim | 1件: D03235
D03235
| 1件: CSF3R CSF3R 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 6件: 2 2, 28, 36, 57, 65, 85 |
69 | Granulocyte Colony Stimulating Factor (GCSF) | 1件: Filgrastim Filgrastim | 1件: D03235
D03235
| 1件: CSF3R CSF3R 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 2件: 36 36, 57 |
70 | Hematopoietic bone marrow transplantation | - | - | - | - | 1件: 36 36 |
71 | Hologene 5 | - | - | - | - | 1件: 36 36 |
72 | Hologene 5 DS | - | - | - | - | 1件: 36 36 |
73 | HOLOGENE17 | - | - | - | - | 1件: 36 36 |
74 | HOLOGENE7 | - | - | - | - | 1件: 36 36 |
75 | HP802-247 | - | - | - | - | 1件: 36 36 |
76 | Human allogeneic adipose tissue-derived mesenchymal stem cells expanded | - | - | - | - | 1件: 36 36 |
77 | Human Allogeneic WJ-MSCs | 1件: Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | 1件: 36 36 |
78 | Human dermal fibroblasts cultured on a bioresorbable polyglactin mesh | - | - | - | - | 1件: 36 36 |
79 | Human fibroblast-derived dermal substitute, Dermagraft | - | - | - | - | 1件: 36 36 |
80 | Human Umbilical Cord Blood-derived Mesenchymal Stem Cells | - | - | - | - | 1件: 36 36 |
81 | ICX-RHY-013 | - | - | - | - | 1件: 36 36 |
82 | Infectogenta | - | - | - | - | 1件: 36 36 |
83 | INM-755 | - | - | - | - | 1件: 36 36 |
84 | INM-755 (cannabinol) cream | 1件: Cannabinol Cannabinol | - | - | - | 1件: 36 36 |
85 | Isotretinoin | 1件: Isotretinoin Isotretinoin | 1件: D00348
D00348
| 2件: RARA RARA, RARB 💬 | 8件: Acute myeloid leukemia Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | 4件: 36 36, 39, 159, 160 |
86 | Ixekizumab | 1件: Ixekizumab Ixekizumab | 1件: D10071
D10071
| 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 6件: 36 36, 37, 107, 162, 269, 271 |
87 | Jojoba oil | 1件: Jojoba oil Jojoba oil | - | - | - | 1件: 36 36 |
88 | Jojoba oil with broccoli sprout extract | 2件: Broccoli Broccoli, Jojoba oil | - | - | - | 1件: 36 36 |
89 | Lorazepam | 1件: Lorazepam Lorazepam | 1件: D00365
D00365
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 2件: 36 36, 231 |
90 | Losartan | 1件: Losartan Losartan | 2件: D00357
D00357
,
D08146
| 1件: AGTR1 AGTR1 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 18件: 17 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
91 | Losartan HEXAL | 1件: Losartan Losartan | 2件: D00357
D00357
,
D08146
| 1件: AGTR1 AGTR1 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 36 36 |
92 | LOSARTAN POTASSIUM | 2件: Losartan Losartan, Potassium | 3件: D00357
D00357
,
D08146
,
D08403
| 1件: AGTR1 AGTR1 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 5件: 36 36, 98, 167, 179, 215 |
93 | LZRSE-Col7A1 Engineered Autologous Epidermal Sheets | - | - | - | - | 1件: 36 36 |
94 | Mesenchymal stem cell transplantation | - | - | - | - | 2件: 36 36, 274 |
95 | Mesenchymal stem cells (MSCs) | - | - | - | - | 3件: 13 13, 36, 96 |
96 | Mesenchymal stem cells derived from bone marrow (BM-MSCs) | - | - | - | - | 1件: 36 36 |
97 | Mesenchymal Stem Cells extracted from bone marrow | - | - | - | - | 1件: 36 36 |
98 | Mesenchymal Stromal Cells | 1件: Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | 10件: 2 2, 36, 49, 51, 60, 96, 97, 107, 274, 284 |
99 | Methoxsalen | 1件: Methoxsalen Methoxsalen | 1件: D00139
D00139
| - | - | 4件: 36 36, 46, 51, 96 |
100 | Morphine | 1件: Morphine Morphine | 3件: D00842
D00842
,
D02271
,
D08233
| 1件: OPRM1 OPRM1 💬 | 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 6件: 36 36, 46, 70, 85, 86, 298 |
101 | Morphine sulphate in intrasite gel | 1件: Morphine Morphine | 3件: D00842
D00842
,
D02271
,
D08233
| 1件: OPRM1 OPRM1 💬 | 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 1件: 36 36 |
102 | Mycophenolate | 1件: Mycophenolic acid Mycophenolic acid | 1件: D05096
D05096
| 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 36件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 |
103 | Mycophenolate mofetil | 2件: Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | 4件: D00752
D00752
,
D05094
,
D05095
,
D05096
| 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 34件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
104 | Na | - | - | - | - | 3件: 36 36, 46, 85 |
105 | Normal Saline | - | - | - | - | 18件: 6 6, 13, 17, 22, 36, 46, 49, 60, 70, 94, 96, 210, 211, 226, 271, 276, 296, 299 |
106 | Occlusive non adherent dressing | - | - | - | - | 1件: 36 36 |
107 | Oleogel-S10 | - | - | - | - | 1件: 36 36 |
108 | ON 01910.NA | - | - | - | - | 1件: 36 36 |
109 | Open Label Topical Beremagene Geperpavec (B-VEC) | - | - | - | - | 1件: 36 36 |
110 | Oral erythromycin | 1件: Erythromycin Erythromycin | 9件: D00140
D00140
,
D00851
,
D01361
,
D02009
,
D02184
,
D02523
,
D02524
,
D02525
,
D04054
| - | - | 1件: 36 36 |
111 | Other: Control wound treatment | - | - | - | - | 1件: 36 36 |
112 | Other: Quality-of-Life Assessment | - | - | - | - | 9件: 34 34, 36, 51, 62, 65, 96, 283, 286, 298 |
113 | Palifermin | 1件: Palifermin Palifermin | 1件: D05338
D05338
| 1件: FGFR2 FGFR2 💬 | 13件: Calcium signaling pathway Calcium signaling pathway, Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Gastric cancer, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells 💬 | 5件: 13 13, 36, 38, 39, 65 |
114 | Phosphate | 1件: Phosphate ion Phosphate ion | - | - | - | 33件: 2 2, 3, 6, 11, 12, 13, 15, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 238, 256, 276, 283, 284, 285, 286, 299 |
115 | Polyphenon E | - | - | - | - | 2件: 13 13, 36 |
116 | Potassium | 1件: Potassium Potassium | 1件: D08403
D08403
| - | - | 12件: 36 36, 46, 66, 67, 88, 94, 98, 115, 167, 179, 215, 235 |
117 | Pregabalin | 1件: Pregabalin Pregabalin | 1件: D02716
D02716
| 4件: CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬 | 7件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 💬 | 5件: 13 13, 36, 46, 70, 298 |
118 | Psorcutan-Ointment | - | - | - | - | 1件: 36 36 |
119 | PTR-01 | - | - | - | - | 1件: 36 36 |
120 | QR-313 | - | - | - | - | 1件: 36 36 |
121 | QR-313 Gel for Topical (Cutaneous) Administration | - | - | - | - | 1件: 36 36 |
122 | Radiation: Total Body Irradiation | - | - | - | - | 7件: 36 36, 49, 51, 60, 65, 283, 284 |
123 | REGE pro dressing | - | - | - | - | 1件: 36 36 |
124 | RGN-137 | - | - | - | - | 1件: 36 36 |
125 | Rigosertib | 1件: Rigosertib Rigosertib | 1件: D10154
D10154
| 1件: PLK1 PLK1 💬 | 4件: Cell cycle Cell cycle, FoxO signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | 1件: 36 36 |
126 | Rigosertib Oral Capsules / Rigosertib Intravenous | 1件: Rigosertib Rigosertib | 1件: D10154
D10154
| 1件: PLK1 PLK1 💬 | 4件: Cell cycle Cell cycle, FoxO signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | 1件: 36 36 |
127 | Rigosertib Sodium | 1件: Rigosertib Rigosertib | 1件: D10154
D10154
| 1件: PLK1 PLK1 💬 | 4件: Cell cycle Cell cycle, FoxO signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | 1件: 36 36 |
128 | Rituximab | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 49件: 6 6, 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 127, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 |
129 | Ropivacaine | 1件: Ropivacaine Ropivacaine | 2件: D04048
D04048
,
D08490
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 3件: 36 36, 46, 70 |
130 | SASS | - | - | - | - | 1件: 36 36 |
131 | SD-101 | - | - | - | - | 1件: 36 36 |
132 | SD-101 dermal cream (3%) | - | - | - | - | 1件: 36 36 |
133 | SD-101 Dermal Cream (6%) | - | - | - | - | 1件: 36 36 |
134 | SD-101-6.0 cream | - | - | - | - | 1件: 36 36 |
135 | See below for FCX-007 description) | - | - | - | - | 1件: 36 36 |
136 | Sericare | - | - | - | - | 1件: 36 36 |
137 | Sericare® | - | - | - | - | 1件: 36 36 |
138 | Serlopitant | 1件: Serlopitant Serlopitant | 1件: D09378
D09378
| 1件: TACR1 TACR1 💬 | 2件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬 | 1件: 36 36 |
139 | Serlopitant Tablet | 1件: Serlopitant Serlopitant | 1件: D09378
D09378
| 1件: TACR1 TACR1 💬 | 2件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬 | 1件: 36 36 |
140 | SimpleCare | - | - | - | - | 1件: 36 36 |
141 | SIN LV Mediated ex vivo transduced autologous fibroblasts expressing codon-optimised COL7A1 | - | - | - | - | 1件: 36 36 |
142 | SIN RV-mediated COL7A1 corrected autologous skin equivalent | - | - | - | - | 1件: 36 36 |
143 | Sirolimus | 1件: Sirolimus Sirolimus | 1件: D00753
D00753
| 1件: MTOR MTOR 💬 | 51件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 36件: 6 6, 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 89, 98, 127, 137, 157, 158, 192, 222, 277, 278, 279, 280, 281, 283, 285, 331 |
144 | Sirolimus 2% | 1件: Sirolimus Sirolimus | 1件: D00753
D00753
| 1件: MTOR MTOR 💬 | 51件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 2件: 36 36, 192 |
145 | Sirolimus, 2% | 1件: Sirolimus Sirolimus | 1件: D00753
D00753
| 1件: MTOR MTOR 💬 | 51件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 2件: 36 36, 192 |
146 | Sulfate | 1件: Sulfate ion Sulfate ion | - | - | - | 27件: 2 2, 3, 6, 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 79, 85, 86, 96, 111, 218, 222, 226, 265, 296, 297, 299 |
147 | Tacrolimus | 1件: Tacrolimus Tacrolimus | 2件: D00107
D00107
,
D08556
| 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 34件: 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 |
148 | Taltz | 1件: Ixekizumab Ixekizumab | 1件: D10071
D10071
| 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 3件: 36 36, 107, 271 |
149 | Taltz 80mg | 1件: Ixekizumab Ixekizumab | 1件: D10071
D10071
| 1件: IL17A IL17A 💬 | 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 36 36 |
150 | TC-MSC | - | - | - | - | 2件: 36 36, 107 |
151 | Tetracyclin | 1件: Tetracycline Tetracycline | 1件: D00201
D00201
| - | - | 1件: 36 36 |
152 | Tetrahydrocannabinol | 1件: Dronabinol Dronabinol | 1件: D00306
D00306
| 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 4件: 8 8, 13, 36, 298 |
153 | THC | - | - | - | - | 5件: 8 8, 13, 36, 46, 96 |
154 | Thymoglobulin | 1件: Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit) | - | - | - | 7件: 36 36, 51, 60, 65, 96, 285, 326 |
155 | THYMOGLOBULINE | 1件: Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit) | - | - | - | 5件: 13 13, 36, 51, 60, 96 |
156 | Thymosin Beta 4 | 1件: Thymosin beta-4 Thymosin beta-4 | - | - | - | 2件: 36 36, 53 |
157 | TolaSure Topical Gel | - | - | - | - | 1件: 36 36 |
158 | Topical Beremagene Geperpavec | - | - | - | - | 1件: 36 36 |
159 | Topical BPM31510 3.0% Cream | - | - | - | - | 1件: 36 36 |
160 | Topical opiod | - | - | - | - | 1件: 36 36 |
161 | Transduced keratinocytes suspension, containing epidermal stem cells genetically corrected with a COL17A1-encoding retroviral vector | - | - | - | - | 1件: 36 36 |
162 | Transduced keratinocytes suspension, containing epidermal stem cells genetically corrected with a COL7A1-encoding retroviral vector | - | - | - | - | 1件: 36 36 |
163 | Transduced keratinocytes suspension, containing epidermal stem cells genetically corrected with a COL7A1-encoding retroviral vector, obtained from secondary culture of ex vivo expanded autologous human keratinocytes. | - | - | - | - | 1件: 36 36 |
164 | Transplantation | - | - | - | - | 1件: 36 36 |
165 | Transvamix (100mg/mL THC, 50mg/mL CBD) | - | - | - | - | 1件: 36 36 |
166 | Trimethoprim | 1件: Trimethoprim Trimethoprim | 2件: D00145
D00145
,
D06236
| - | - | 7件: 36 36, 44, 49, 60, 61, 85, 299 |
167 | Triterpene dry extract from birch cork | - | - | - | - | 1件: 36 36 |
168 | Unavailable | - | - | - | - | 1件: 36 36 |
169 | Vehicle | - | - | - | - | 4件: 6 6, 36, 160, 192 |
170 | Vehicle (SD-101 0%) | - | - | - | - | 1件: 36 36 |
171 | Vehicle Cream | - | - | - | - | 1件: 36 36 |
172 | Vehicle Topical Gel | - | - | - | - | 1件: 36 36 |
173 | VPD-737 | - | - | - | - | 1件: 36 36 |
174 | WHARTON’S JELLY DERIVED MESENCHYMAL STEM CELLS | - | - | - | - | 1件: 36 36 |
175 | WJ-MSCs | 1件: Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | 1件: 36 36 |
176 | Zorblisa | - | - | - | - | 1件: 36 36 |